7-(2-BUTYN-1-YL)-8-((3R)-3-(1,3-DIHYDRO-1,3-DIOXO-2H-ISOINDOL-2-YL)-1-PIPERIDINYL)-3,7-DIHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-1H-PURINE-2,6-DIONE
UNII E5E8KN349S
Substance Identification & Data
This profile provides standardized clinical and technical data for 7-(2-butyn-1-yl)-8-((3r)-3-(1,3-dihydro-1,3-dioxo-2h-isoindol-2-yl)-1-piperidinyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-1h-purine-2,6-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) E5E8KN349S.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 886588-63-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C33H30N8O4 OXVXJPINFRNEPM-OAQYLSRUSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 7-(2-butyn-1-yl)-8-((3r)-3-(1,3-dihydro-1,3-dioxo-2h-isoindol-2-yl)-1-piperidinyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-1h-purine-2,6-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.